Khorana Jung*
Parkinson's disease (PD) is the second most prevalent neurodegenerative ailment and is caused by human physiological function. Dopamine agonists, which replicate dopamine's natural activity in the brain and directly stimulate dopamine receptors, are one of the most popular treatments for Parkinson's disease now available. Pharmaceutical medications currently available only provide brief respite from the condition. Because Phytocompounds can form secondary metabolites with novel chemical structures, they have been highlighted as a prospective research target in the search for new medicinal molecules. The drug development of Parkinson's disease has been studied utilising computational tools in the future.
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi